S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
LON:EVG

Evgen Pharma (EVG) Share Price, News & Analysis

GBX 0.88
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
0.88
0.88
50-Day Range
0.88
1.85
52-Week Range
0.81
4.05
Volume
116,116 shs
Average Volume
1.87 million shs
Market Capitalization
£2.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EVG stock logo

About Evgen Pharma Stock (LON:EVG)

Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

EVG Stock Price History

EVG Stock News Headlines

Evgen Pharma (LON:EVG) Sets New 52-Week Low at $0.90
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Evgen Pharma Share Chat
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Evgen Pharma Shares Fall on Ending of License Deal
Evgen Pharma Shares Rise on Drug Candidate Data
Market movers: Electricity generators fall on revenue cap reports
See More Headlines
Receive EVG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evgen Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/15/2020
Today
3/28/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
£-3,350,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 0.50 per share
Book Value
GBX 1 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.34 million
Optionable
Not Optionable
Beta
1.47
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Huw Jones BSc (Age 65)
    Ph.D., CEO & Executive Director
    Comp: $304.73k
  • Mr. Toni Haenninen (Age 47)
    CFO & Director
  • Dr. Helen Kuhlman
    Chief Business Officer
  • Dr. Glen Clack FFPM
    M.D., Chief Medical Officer

EVG Stock Analysis - Frequently Asked Questions

How have EVG shares performed in 2024?

Evgen Pharma's stock was trading at GBX 1.60 on January 1st, 2024. Since then, EVG stock has decreased by 45.3% and is now trading at GBX 0.88.
View the best growth stocks for 2024 here
.

How were Evgen Pharma's earnings last quarter?

Evgen Pharma plc (LON:EVG) announced its quarterly earnings results on Monday, June, 15th. The company reported ($2.10) earnings per share for the quarter, meeting analysts' consensus estimates of ($2.10).

How do I buy shares of Evgen Pharma?

Shares of EVG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:EVG) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners